• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Nestle Aimmune Peanut Allergy Drug
Newsletters
Nestlé invests another $200 million in Aimmune’s peanut allergy drug
By Sy MukherjeeFebruary 5, 2020
Gates Foundation Coronavirus Donation
Health
The Gates Foundation is pledging up to $100 million for the fight against coronavirus
By Sy MukherjeeFebruary 5, 2020
What Andreessen’s ‘Bio Fund III’ means for healthcare
Newsletters
What Andreessen’s ‘Bio Fund III’ means for healthcare
By Sy MukherjeeFebruary 4, 2020
A vaccine that looked promising for HIV doesn’t work
Newsletters
A vaccine that looked promising for HIV doesn’t work
By Sy MukherjeeFebruary 3, 2020
Coronavirus vaccine development
Health
The first coronavirus drug candidate is set for testing in China
By Sy MukherjeeFebruary 3, 2020
For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment
Health
For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment
By Sy MukherjeeFebruary 2, 2020
Vertex Pharmaceuticals Earnings 2019
Newsletters
Vertex CEO takes an earnings victory lap right before he exits
By Sy MukherjeeJanuary 31, 2020
Eli Lilly Earnings Diabetes Sales
Newsletters
Eli Lilly smashed Wall Street projections thanks to its diabetes drugs
By Sy MukherjeeJanuary 30, 2020
Wuhan coronavirus transmission
Health
How the Wuhan coronavirus spreads and what’s being done about it
By Sy MukherjeeJanuary 30, 2020
Novartis Zolgensma Gene Therapy Sales
Newsletters
Why a drug that costs $2.1 million per dose is on a sales streak
By Sy MukherjeeJanuary 29, 2020
Bloomberg Drug Prices
Newsletters
One drug, one patent?
By Sy MukherjeeJanuary 28, 2020
Michael Bloomberg Drug Pricing Patents
Health
Michael Bloomberg’s radical plan to cut prescription drug costs
By Sy MukherjeeJanuary 28, 2020
Kobe Bryant Death Science of Grief
Newsletters
Kobe Bryant and the science of grief
By Sy MukherjeeJanuary 27, 2020
China Coronavirus Vaccine
Newsletters
The hunt for a coronavirus vaccine begins
By Sy MukherjeeJanuary 24, 2020
Telehealth Ro Pfizer Viagra
Health
Telehealth startup Ro partners with Pfizer to give its ED business a boost
By Sy MukherjeeJanuary 24, 2020
1...
  • 20
  • 21
  • 22
  • 23
  • 24
...100
Most Popular
Real Estate
The millennial generation is split in 2: an older crowd with boomer-style comfort, a younger set going 'back to the early 1900s'placeholder alt text
By Nick LichtenbergJuly 25, 2026
Economy
College-educated women are snapping up the highest-earning men without college degrees, leaving the rest further behindplaceholder alt text
By Mia OsmonbekovJuly 26, 2026
Success
An 11-year-old is cleaning his neighbors' trash cans for $10 each—he now has 100K followers as teens face the worst summer job market since 1948placeholder alt text
By Orianna Rosa RoyleJuly 25, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.